BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 19428908)

  • 1. A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.
    Wang J; Chen L; Chen F; Zhang X; Zhang Y; Baseman J; Perdue S; Yeh IT; Shain R; Holland M; Bailey R; Mabey D; Yu P; Zhong G
    Vaccine; 2009 May; 27(22):2967-80. PubMed ID: 19428908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodominant regions of a Chlamydia trachomatis type III secretion effector protein, Tarp.
    Wang J; Zhang Y; Yu P; Zhong G
    Clin Vaccine Immunol; 2010 Sep; 17(9):1371-6. PubMed ID: 20668138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
    Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
    Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.
    Igietseme JU; Uriri IM; Kumar SN; Ananaba GA; Ojior OO; Momodu IA; Candal DH; Black CM
    Infect Immun; 1998 Sep; 66(9):4030-5. PubMed ID: 9712743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with chlamydial type III secretion antigens reduces vaginal shedding and prevents fallopian tube pathology following live C. muridarum challenge.
    Bulir DC; Liang S; Lee A; Chong S; Simms E; Stone C; Kaushic C; Ashkar A; Mahony JB
    Vaccine; 2016 Jul; 34(34):3979-85. PubMed ID: 27325352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective immunity against mouse upper genital tract pathology correlates with high IFNγ but low IL-17 T cell and anti-secretion protein antibody responses induced by replicating chlamydial organisms in the airway.
    Lu C; Zeng H; Li Z; Lei L; Yeh IT; Wu Y; Zhong G
    Vaccine; 2012 Jan; 30(2):475-85. PubMed ID: 22079265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of antigen-specific antibody responses associated with upper genital tract pathology in mice infected with Chlamydia muridarum.
    Zeng H; Gong S; Hou S; Zou Q; Zhong G
    Infect Immun; 2012 Mar; 80(3):1098-106. PubMed ID: 22158739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins.
    Sharma J; Zhong Y; Dong F; Piper JM; Wang G; Zhong G
    Infect Immun; 2006 Mar; 74(3):1490-9. PubMed ID: 16495519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner.
    Li Z; Zhong Y; Lei L; Wu Y; Wang S; Zhong G
    BMC Microbiol; 2008 Jun; 8():90. PubMed ID: 18541036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole genome identification of C. trachomatis immunodominant antigens after genital tract infections and effect of antibiotic treatment of pigtailed macaques.
    Patton DL; Teng A; Randall A; Liang X; Felgner PL; de la Maza LM
    J Proteomics; 2014 Aug; 108():99-109. PubMed ID: 24862987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains.
    Su H; Messer R; Whitmire W; Hughes S; Caldwell HD
    Infect Immun; 2000 Jan; 68(1):192-6. PubMed ID: 10603387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines.
    Finco O; Frigimelica E; Buricchi F; Petracca R; Galli G; Faenzi E; Meoni E; Bonci A; Agnusdei M; Nardelli F; Bartolini E; Scarselli M; Caproni E; Laera D; Zedda L; Skibinski D; Giovinazzi S; Bastone R; Ianni E; Cevenini R; Grandi G; Grifantini R
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9969-74. PubMed ID: 21628568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans.
    Wang J; Zhang Y; Lu C; Lei L; Yu P; Zhong G
    J Immunol; 2010 Aug; 185(3):1670-80. PubMed ID: 20581152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Chlamydia trachomatis Antigens Recognized by T Cells From Highly Exposed Women Who Limit or Resist Genital Tract Infection.
    Russell AN; Zheng X; O'Connell CM; Wiesenfeld HC; Hillier SL; Taylor BD; Picard MD; Flechtner JB; Zhong W; Frazer LC; Darville T
    J Infect Dis; 2016 Dec; 214(12):1884-1892. PubMed ID: 27738051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with MIP or Pgp3 induces cross-serovar protection against chlamydial genital tract infection in mice.
    Luan X; Peng B; Li Z; Tang L; Chen C; Chen L; Wu H; Sun Z; Lu C
    Immunobiology; 2019 Mar; 224(2):223-230. PubMed ID: 30558842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide identification of Chlamydia trachomatis antigens associated with trachomatous trichiasis.
    Lu C; Holland MJ; Gong S; Peng B; Bailey RL; Mabey DW; Wu Y; Zhong G
    Invest Ophthalmol Vis Sci; 2012 May; 53(6):2551-9. PubMed ID: 22427578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice.
    Li Z; Wang S; Wu Y; Zhong G; Chen D
    Sci China C Life Sci; 2008 Nov; 51(11):973-80. PubMed ID: 18989639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of protective immunity against Chlamydia muridarum intracervical infection in DBA/1j mice.
    Tang L; Yang Z; Zhang H; Zhou Z; Arulanandam B; Baseman J; Zhong G
    Vaccine; 2014 Mar; 32(12):1407-13. PubMed ID: 24188757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with a combination of integral chlamydial antigens and a defined secreted protein induces robust immunity against genital chlamydial challenge.
    Li W; Murthy AK; Guentzel MN; Chambers JP; Forsthuber TG; Seshu J; Zhong G; Arulanandam BP
    Infect Immun; 2010 Sep; 78(9):3942-9. PubMed ID: 20605976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane.
    Bannantine JP; Griffiths RS; Viratyosin W; Brown WJ; Rockey DD
    Cell Microbiol; 2000 Feb; 2(1):35-47. PubMed ID: 11207561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.